MyAverix Finance
NS · Healthcare
Cresanto Global Ltd (531207)
Pharmaceuticals & Biotechnology
Cresanto Global Ltd (531207) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $18.90M, P/E ratio is -4.60, net margin is -201.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 531207
Cresanto Global Ltd (531207) — FAQ
What is Cresanto Global Ltd's market cap?
Cresanto Global Ltd (531207) has a reported market cap of $18.90M (data as of 2026-07-10).
What is 531207's P/E ratio?
The price-to-earnings (P/E) ratio for Cresanto Global Ltd (531207) is -4.60 (data as of 2026-07-10).
Does Cresanto Global Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Cresanto Global Ltd (531207). Check the MyAverix Finance app for the latest dividend data.
What sector is Cresanto Global Ltd in?
Cresanto Global Ltd (531207) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 531207 listed on?
531207 is listed on NS.
What is Cresanto Global Ltd's net margin?
Cresanto Global Ltd (531207) reports a net margin of -201.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.